Provided by Tiger Fintech (Singapore) Pte. Ltd.

SELLAS Life Sciences Group Inc.

1.41
+0.01000.71%
Volume:2.75M
Turnover:3.83M
Market Cap:128.09M
PE:-2.79
High:1.45
Open:1.43
Low:1.35
Close:1.40
Loading ...

SELLAS Announces Positive Overall Survival and Overall Response Rate Data from the Phase 2 Trial of SLS009 in r/r AML

GlobeNewswire
·
09 Dec 2024

BUZZ-Sellas rises on preclinical data for blood cancer drug

Reuters
·
27 Nov 2024

Sellas Shares up 3.8% After Co Reports Preclinical Data for Blood Cancer Drug

THOMSON REUTERS
·
27 Nov 2024

Sellas Life Sciences announces data from preclinical studies of SLS009

TIPRANKS
·
27 Nov 2024

BRIEF-Sellas Announces Positive Data From Preclinical Studies Indicating Asxl1 Mutations As Predictor Of Response To SLS009 In Solid Cancers

Reuters
·
27 Nov 2024

Sellas Life Sciences Group Inc: Preselection Method for Cancers Responding to Sls009

THOMSON REUTERS
·
27 Nov 2024

Sellas Announces Positive Data From Preclinical Studies Indicating Asxl1 Mutations as Predictor of Response to Sls009 in Solid Cancers

THOMSON REUTERS
·
27 Nov 2024

Sellas: Asxl1 Mutations Predictably Identified in Colorectal Cancer and Non-Small Cell Lung Cancer in Addition to Hematologic Malignancies

THOMSON REUTERS
·
27 Nov 2024

SELLAS Announces Positive Data from Preclinical Studies Indicating ASXL1 Mutations as Predictor of Response to SLS009 in Solid Cancers

GlobeNewswire
·
27 Nov 2024

Billionaire Michael Bloomberg Wants to Crush Boeing's Space Dream

Motley Fool
·
24 Nov 2024

Sims Lifecycle Services Listed as a Representative Vendor in the 2024 Gartner® "Market Guide for IT Asset Disposition"

Business Wire
·
22 Nov 2024

We're A Little Worried About SELLAS Life Sciences Group's (NASDAQ:SLS) Cash Burn Rate

Simply Wall St.
·
16 Nov 2024

Sellas Life Sciences Group Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
14 Nov 2024

SELLAS Life Sciences Gr Q3 2024 GAAP EPS $(0.10) Beats $(0.13) Estimate

Benzinga
·
14 Nov 2024

BRIEF-SELLAS Life Sciences Q3 Net Income USD -7.108 Million

Reuters
·
14 Nov 2024

Sellas Life Sciences Q3 Basic EPS USD -0.1

THOMSON REUTERS
·
14 Nov 2024

Sellas Life Sciences Q3 Operating Expenses USD 7.329 Million

THOMSON REUTERS
·
14 Nov 2024

Press Release: SELLAS Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Dow Jones
·
14 Nov 2024

Sellas Life Sciences options imply 22.6% move in share price post-earnings

TIPRANKS
·
12 Nov 2024

Trump victory expected to boost Musk's Mars dream

CNA
·
08 Nov 2024